A Brazilian perspective on developing tests for Covid-19
There is a lot of difference between Brazil and Denmark - not the least when it comes to the Covid-19 outbreak - which put a pressure on the Brazilian healthcare system to quickly develop a testing method.
Exploring Bioscience - digital festival presents Dr. Celso Granato, Specialist in Infectious Diseases and Clinical Pathology, a member of the Brazilian Societies of Infectious Diseases and of Clinical Pathology and Clinical Director at Fleury Laboratory for Diagnosis, Brazil.
Dr. Granato will let us in on the test he and his team have developed as a fast way to diagnose Covid-19 and how these can be used for future pandemics.
About the speaker
Dr. Celso Granato holds a medical degree by the University of São Paulo (FMUSP) and medical residency in the Department of Infections and Parasitic Diseases of Hospital das Clínicas ( School of Medicine, University of Sao Paulo_HCFMUSP). He performed his researches fellowship at the Central Institute of Microbiology and Immunology in the University of Hamburg in Germany, Hepatitis and AIDS at Claude Bernard Lyon University, in France; and Retrovirus at Cornell University in USA.
Dr. Granato has the title of specialist in Infectious Diseases and Clinical Pathology and is a member of the Brazilian Societies of Infectious Diseases and of Clinical Pathology. Since 1983, he is Clinical Director at Fleury Laboratory for Diagnosis. In addition, in the last 30 years, he has been responsible for several scientific projects, conducted by Fleury Laboratories and by Federal University of São Paulo (UNIFESP_School of Medicine).
IDA laver hvert år et væld af webinarer, som spænder fra dybt fagtekniske emner inden for naturvidenskab, it og engineering til konkrete råd, om hvordan du håndterer dit arbejdsliv.
De foregår live, men efterfølgende kan du se dem i optaget version på IDAs hjemmeside.
Vær opmærksom på, det ikke er tilladt at dele hverken zoomlinket eller link til video med andre, eller at optage lyd og billeder af webinaret.